| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 19.31▲ | 19.25▲ | 19.25▲ | 19.25▲ | 18.44▲ |
| MA10 | 19.29▲ | 19.27▲ | 19.34▼ | 18.74▲ | 18.65▲ |
| MA20 | 19.26▲ | 19.33▼ | 19.35▼ | 18.22▲ | 16.39▲ |
| MA50 | 19.26▲ | 19.27▲ | 18.89▲ | 18.39▲ | 14.17▲ |
| MA100 | 19.34▼ | 18.85▲ | 18.24▲ | 15.82▲ | 12.93▲ |
| MA200 | 19.39▼ | 18.19▲ | 18.49▲ | 14.08▲ | 11.14▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.011▲ | -0.022▼ | -0.052▼ | 0.173▲ | 0.160▲ |
| RSI | 62.192▲ | 51.241▲ | 55.018▲ | 62.855▲ | 68.546▲ |
| STOCH | 74.411 | 24.012 | 20.340 | 89.574▲ | 65.859 |
| WILL %R | -18.519▲ | -63.333 | -73.881 | -16.583▲ | -7.814▲ |
| CCI | 139.525▲ | -19.845 | -49.221 | 106.264▲ | 93.308 |
|
Monday, October 27, 2025 06:58 AM
Newmark Group, Inc. (Nasdaq: NMRK) (Newmark or the Company), a leading commercial real estate advisor and service provider to large institutional investors, global corporations, and other owners and ...
|
|
Sunday, October 26, 2025 03:05 AM
EVX-01 is a personalized peptide-based cancer vaccine for first-line treatment of multiple advanced solid cancers and is Evaxion’s lead clinical asset. Flaten informed investors that the two-year data ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/10/25 | 19.41 | 19.62 | 19.165 | 19.34 | 982,683 |
| 24/10/25 | 19.64 | 19.835 | 19.16 | 19.48 | 1,023,842 |
| 23/10/25 | 19.26 | 19.68 | 18.915 | 19.35 | 1,693,643 |
| 22/10/25 | 18.93 | 19.27 | 18.655 | 19.26 | 1,077,565 |
| 21/10/25 | 18.52 | 18.90 | 18.27 | 18.80 | 1,115,859 |
| 20/10/25 | 18.35 | 18.75 | 18.19 | 18.60 | 826,037 |
| 17/10/25 | 17.85 | 18.29 | 17.70 | 18.23 | 999,083 |
| 16/10/25 | 18.49 | 18.55 | 17.88 | 18.01 | 1,137,491 |
| 15/10/25 | 18.07 | 18.44 | 17.90 | 18.41 | 1,205,783 |
| 14/10/25 | 17.16 | 18.065 | 17.16 | 17.92 | 1,027,352 |
|
|
||||
|
|
||||
|
|